GO:0008237 metallopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008237 metallopeptidase activity describes catalysis of peptide bond hydrolysis by a water molecule activated by one or two metal ions, with charged amino acid side chains serving as metal ligands.
• Metallopeptidases are among the most diverse protease families and include matrix metalloproteinases (MMPs), ADAM/ADAMTS sheddases, and snake venom metalloproteinases.
• The catalytic mechanism requires a metal cofactor, typically zinc, held by a conserved motif such as HEXXH, and the metal-bound hydroxide acts as the nucleophile.
• Metallopeptidase activity is essential for extracellular matrix remodeling, growth factor shedding, and cell-surface protein processing, and its dysregulation is linked to cancer, inflammation, and tissue injury.
• Functional studies of metallopeptidases rely on CRISPR knockout, point-mutation, knock-in, and overexpression models combined with activity assays, proteomics, and imaging.
• Metallopeptidase activity can be regulated at multiple levels, including gene expression, zymogen activation, and inhibition by endogenous inhibitors such as TIMPs.
Description
Metallopeptidase activity (GO:0008237) is a molecular function that catalyzes the hydrolysis of peptide bonds using a water molecule that is activated by one or two metal ions. This mechanism is fundamental to numerous biological processes, from extracellular matrix turnover to the release of membrane-bound signaling molecules. Researchers study metallopeptidases because they are central to development, immunity, and disease, and because they are highly druggable targets. The QuickGO definition states that catalysis occurs by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. This article integrates the authoritative GO definition with verified literature to provide a research-grade overview of metallopeptidase activity, its key genes, regulatory mechanisms, disease links, and experimental approaches.
metallopeptidase activity At A Glance
| GO ID | GO:0008237 |
|---|---|
| GO term | metallopeptidase activity |
| Ontology | molecular_function |
| Synonym | metalloprotease activity; metalloproteinase activity |
| Definition | Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. |
| Major function | Proteolytic cleavage of peptide bonds using a metal ion cofactor, typically zinc. |
| Metal cofactor | Zinc is the most common metal, but cobalt, manganese, nickel, and copper can also be used. |
| Catalytic residues | Charged amino acid side chains, often histidine, glutamate, aspartate, or cysteine, coordinate the metal ion. |
| Representative families | Matrix metalloproteinases (MMPs), ADAMs, ADAMTSs, and snake venom metalloproteinases. |
What Is GO:0008237?
In simple terms, metallopeptidase activity is the ability of an enzyme to cut other proteins by using a metal ion, usually zinc, to activate a water molecule that performs the cut. According to the Gene Ontology, GO:0008237 is defined as catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. This activity is classified as a molecular_function and is synonymous with metalloprotease activity and metalloproteinase activity.
Why Is metallopeptidase activity Important in Cell Biology?
Metallopeptidase activity is important because it controls the proteolytic processing of a vast array of substrates, including extracellular matrix components, cytokines, growth factors, and cell-surface receptors. This activity is essential for normal physiological processes such as tissue remodeling, angiogenesis, and immune cell migration, and its dysregulation contributes to cancer progression, inflammatory diseases, and tissue degeneration. Understanding metallopeptidase activity at the molecular level enables the development of selective inhibitors and the design of CRISPR-based models to dissect gene function.
• Metallopeptidases are involved in extracellular matrix degradation and remodeling, which is critical for tissue development and repair.
• They regulate the bioavailability of growth factors and cytokines by shedding them from the cell surface.
• Dysregulated metallopeptidase activity is associated with cancer invasion and metastasis.
• Metallopeptidases play roles in inflammatory and immune responses by processing chemokines and cytokines.
• Snake venom metalloproteinases are prototypes for understanding the catalytic mechanism and inhibitor design.
• Metallopeptidase activity is required for oocyte detachment from the zona pellucida in mouse models.
• Exercise-induced improvements in cerebral ischemia are linked to downregulation of MMP12, a metallopeptidase.
• Gut microbiome-adipose crosstalk can modulate soluble IL-6 receptor, which may involve metallopeptidase activity.
• Metallopeptidases are targets for drug discovery in cancer, arthritis, and cardiovascular disease.
• CRISPR screens can identify novel metallopeptidase substrates and regulators.
What Happens During metallopeptidase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the protein it needs to cut.
Metallopeptidases recognize specific substrate sequences or structural features, often through exosite interactions distant from the active site. This binding step positions the scissile peptide bond near the catalytic metal ion and ensures cleavage specificity.
Metal ion coordination and water activation
In simple terms: A metal ion holds a water molecule and makes it ready to cut.
In the catalytic site, one or two metal ions, typically zinc, are coordinated by conserved residues such as histidines and glutamates. The metal ion polarizes a water molecule, lowering its pKa and converting it into a nucleophilic hydroxide that attacks the carbonyl carbon of the peptide bond.
Peptide bond hydrolysis
In simple terms: The activated water breaks the peptide bond.
The hydroxide attacks the scissile peptide bond, forming a tetrahedral intermediate that collapses to release the two cleavage products. The metal ion stabilizes the transition state and the leaving group, facilitating catalysis.
Product release and enzyme recycling
In simple terms: The cut pieces are released, and the enzyme is ready to cut again.
After cleavage, the products diffuse away, and the enzyme returns to its resting state, ready for another round of catalysis. Some metallopeptidases undergo conformational changes that regulate this cycle.
Key Genes Involved in GO:0008237 metallopeptidase activity
The following table lists representative genes and proteins that possess metallopeptidase activity (GO:0008237) and are widely studied in biomedical research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMP1 | Collagenase that degrades interstitial collagens | Cancer invasion, arthritis, tissue remodeling |
| MMP2 | Gelatinase A, degrades type IV collagen | Angiogenesis, tumor metastasis |
| MMP9 | Gelatinase B, degrades extracellular matrix | Inflammation, cancer, neuroinflammation |
| MMP12 | Macrophage metalloelastase | Cerebral ischemia, microglia polarization |
| MMP14 | Membrane-type MMP, activates proMMP2 | Cell migration, cancer |
| ADAM17 | Sheddase for TNF-alpha and EGFR ligands | Inflammation, cancer, immune regulation |
| ADAM10 | Sheddase for Notch and amyloid precursor protein | Neurodegeneration, development |
| ADAMTS1 | Aggrecanase and anti-angiogenic factor | Cartilage degradation, cancer |
| ADAMTS13 | von Willebrand factor cleaving protease | Thrombotic thrombocytopenic purpura |
| ACE | Angiotensin-converting enzyme | Hypertension, cardiovascular disease |
| ACE2 | Receptor for SARS-CoV-2, carboxypeptidase | COVID-19, immune modulation |
| Neprilysin | Degrades amyloid-beta and natriuretic peptides | Alzheimer's disease, heart failure |
| Insulysin | Insulin-degrading enzyme | Diabetes, amyloid-beta clearance |
| MMP7 | Matrilysin, degrades ECM and activates defensins | Cancer, innate immunity |
| MMP13 | Collagenase 3, degrades fibrillar collagens | Osteoarthritis, bone remodeling |
| ADAMTS4 | Aggrecanase-1 | Osteoarthritis, cartilage breakdown |
| ADAMTS5 | Aggrecanase-2 | Osteoarthritis, development |
How Is metallopeptidase activity Regulated?
Metallopeptidase activity is regulated at multiple levels. Gene expression is controlled by transcription factors and epigenetic mechanisms in response to growth factors, cytokines, and stress. Most metallopeptidases are synthesized as inactive zymogens that require proteolytic removal of a pro-domain for activation. Endogenous inhibitors, such as tissue inhibitors of metalloproteinases (TIMPs) and alpha-2-macroglobulin, bind to active enzymes and block catalysis. Additionally, compartmentalization and post-translational modifications, including phosphorylation and glycosylation, modulate activity. In disease contexts, inflammatory mediators can upregulate metallopeptidase expression, as seen with MMP12 in cerebral ischemia.
metallopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MMP9 | Cancer metastasis and neuroinflammation | CRISPR knockout in cancer cell lines; xenograft models |
| MMP12 | Cerebral ischemia and microglia polarization | Knockout mice subjected to treadmill exercise |
| ACE2 | COVID-19 and immune modulation | Knock-in humanized mouse models; overexpression cell lines |
| ADAM17 | Inflammatory diseases and cancer | Point-mutation knock-in to disable sheddase activity |
| MMP14 | Cancer invasion and angiogenesis | Knockout and overexpression in endothelial cells |
Cancer
Metallopeptidases such as MMP2, MMP9, and MMP14 promote tumor invasion and metastasis by degrading extracellular matrix barriers and releasing growth factors. Elevated metallopeptidase activity correlates with poor prognosis in multiple cancers, and inhibitors have been explored as therapeutic agents. In triple-negative breast cancer models, metformin treatment has been shown to affect cancer cells and may influence metallopeptidase-related pathways.
Neurodegeneration and neuroinflammation
Metallopeptidases contribute to blood-brain barrier disruption and neuronal injury after cerebral ischemia, with MMP12 downregulation associated with improved outcomes in treadmill exercise models. Neprilysin and insulysin degrade amyloid-beta, and their dysfunction is linked to Alzheimer's disease pathology.
Infectious and immune-mediated diseases
ACE2, a metallopeptidase, serves as the receptor for SARS-CoV-2 and modulates immune responses, highlighting the role of metallopeptidases in viral entry and immune regulation. ADAM17-mediated shedding of TNF-alpha is a key step in inflammatory cytokine release.
Reproductive biology
Metallopeptidase activity mediates the initial detachment of mouse oocytes from the zona pellucida, a process essential for fertilization. This highlights the importance of metallopeptidases in reproductive physiology.
From metallopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of metallopeptidase X reduce tumor invasion? | CRISPR knockout in cancer cell lines and mouse xenografts |
| Does a specific catalytic residue mutation abolish activity? | Point mutation (e.g., HEXXH motif) knock-in cell lines |
| Can a tagged version track subcellular localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression mimic a disease phenotype? | Overexpression cell models and transgenic mice |
| Which substrates are cleaved by a metallopeptidase? | CRISPR knockout combined with proteomics and degradomics |
| Does exercise modulate metallopeptidase expression? | Knockout mice with treadmill exercise intervention |
How to Study the metallopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic peptide assay | Enzymatic cleavage rate | Inhibitor screening and kinetic analysis |
| TAILS proteomics | N-terminal peptides and cleavage sites | Substrate discovery for metallopeptidases |
| Western blot | Protein expression and processing | Zymogen activation and inhibitor studies |
| Immunofluorescence | Subcellular localization | Trafficking and co-localization |
| CRISPR knockout screen | Gene essentiality and pathway regulators | Identifying modifiers of metallopeptidase activity |
| Activity-based probes | Active enzyme population | In vivo imaging of metallopeptidase activity |
| qRT-PCR | mRNA expression levels | Regulation by cytokines or exercise |
Activity assays
Metallopeptidase activity can be measured using fluorogenic or colorimetric peptide substrates that release a detectable signal upon cleavage. These assays are used to screen inhibitors and validate enzyme function in cell lysates or purified preparations.
Proteomics and degradomics
Mass spectrometry-based proteomics, including terminal amine isotopic labeling of substrates (TAILS), identifies natural substrates and cleavage sites of metallopeptidases. This approach provides global maps of proteolytic events in cells and tissues.
Imaging and localization
Fluorescent tagging or immunofluorescence can visualize metallopeptidase localization and trafficking in live cells. Activity-based probes enable detection of active enzymes in situ.
Genetic screens
CRISPR knockout screens can identify genes that regulate metallopeptidase activity or mediate sensitivity to inhibitors. Such screens are powerful for discovering novel components of proteolytic pathways.
How CRISPR Can Be Used to Study GO:0008237 metallopeptidase activity
Knockout
CRISPR knockout of a metallopeptidase gene eliminates its activity, allowing researchers to assess loss-of-function phenotypes in cell models and animals. This approach is widely used to validate substrate cleavage and disease contributions.
Point Mutation
Introducing point mutations in catalytic residues, such as the histidines in the HEXXH motif, abolishes metallopeptidase activity while preserving protein structure. This helps distinguish catalytic activity from non-catalytic functions.
Knock-in
Knock-in of epitope tags, fluorescent proteins, or disease-associated mutations enables tracking and functional studies of metallopeptidases in their native genomic context. This is valuable for studying localization and regulation.
Overexpression
Overexpression of wild-type or mutant metallopeptidases in cell lines can mimic pathological states and test gain-of-function effects. It is often used in combination with knockout to confirm specificity.
How EDITGENE Supports metallopeptidase activity Research
Researchers studying metallopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a biological process or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of metallopeptidases and their regulators.
Contact EDITGENE today to design your custom CRISPR model for metallopeptidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MMP11 Knockout MIA PaCa-2 Cell Line | EDJ-KQ58 | Human | 4320 | Details Get a Quote |
| MMP7 Knockout HEK293 Cell Line | EDJ-KQ114 | Human | 4316 | Details Get a Quote |
| ERAP1 Knockout HEK293T Cell Line | EDJ-KQ152 | Human | 51752 | Details Get a Quote |
| ADAM9 Knockout HEK293 Cell Line | EDJ-KQ242 | Human | 8754 | Details Get a Quote |
| ADAM17 Knockout HEK293 Cell Line | EDC07796 | Human | 6868 | Details Get a Quote |
| MMP3 Knockout HEK293 Cell Line | EDJ-KQ1483 | Human | 4314 | Details Get a Quote |
| MMP14 Knockout HEK293 Cell Line | EDJ-KQ1484 | Human | 4323 | Details Get a Quote |
| MMP11 Knockout HEK293 Cell Line | EDJ-KQ1930 | Human | 4320 | Details Get a Quote |
| ANPEP Knockout HEK293 Cell Line | EDJ-KQ1953 | Human | 290 | Details Get a Quote |
| MYSM1 Knockout HEK293 Cell Line | EDJ-KQ2096 | Human | 114803 | Details Get a Quote |
| MBTPS2 Knockout HEK293 Cell Line | EDJ-KQ2239 | Human | 51360 | Details Get a Quote |
| CPB2 Knockout HEK293 Cell Line | EDJ-KQ2428 | Human | 1361 | Details Get a Quote |
| ECEL1 Knockout HEK293 Cell Line | EDJ-KQ2505 | Human | 9427 | Details Get a Quote |
| STAMBP Knockout HEK293 Cell Line | EDJ-KQ2722 | Human | 10617 | Details Get a Quote |
| ERAP2 Knockout HEK293 Cell Line | EDC10309 | Human | 64167 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »
Frequently Asked Questions About metallopeptidase activity
What is metallopeptidase activity?
Metallopeptidase activity (GO:0008237) is the catalysis of peptide bond hydrolysis by a water molecule activated by one or two metal ions, with charged amino acid side chains serving as metal ligands.
What genes are involved in metallopeptidase activity?
Key genes include MMPs (e.g., MMP1, MMP2, MMP9, MMP12, MMP14), ADAMs (e.g., ADAM10, ADAM17), ADAMTSs (e.g., ADAMTS1, ADAMTS13), ACE, ACE2, neprilysin, and insulysin.
What is the GO ID for metallopeptidase activity?
The Gene Ontology ID for metallopeptidase activity is GO:0008237.
How is metallopeptidase activity regulated?
It is regulated by gene expression, zymogen activation, endogenous inhibitors such as TIMPs, and post-translational modifications.
What diseases are associated with metallopeptidase activity?
Dysregulated metallopeptidase activity is linked to cancer, neurodegeneration, inflammatory diseases, and reproductive disorders.
What is the catalytic mechanism of metallopeptidases?
A metal ion, typically zinc, coordinates a water molecule, making it nucleophilic; the activated water attacks the peptide bond, leading to hydrolysis.
How can I study metallopeptidase activity in the lab?
Common methods include fluorogenic peptide assays, proteomics, Western blot, immunofluorescence, and CRISPR screens.
What are metallopeptidase inhibitors?
Endogenous inhibitors include TIMPs and alpha-2-macroglobulin; synthetic inhibitors are used in cancer and arthritis research.
Can CRISPR be used to study metallopeptidases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect metallopeptidase function.
What is the role of metallopeptidases in cancer?
They promote tumor invasion and metastasis by degrading extracellular matrix and releasing growth factors.
Conclusion
Metallopeptidase activity (GO:0008237) is a fundamental molecular function that governs proteolysis in diverse biological contexts. Its mechanisms, key genes, and disease associations are well documented, and CRISPR-based models offer powerful tools to dissect its roles. EDITGENE provides end-to-end CRISPR services to support metallopeptidase research, from knockout to library screening.
References
- 1. Nagase H. 2001. Metalloproteases.. Curr Protoc Protein Sci Chapter 21:21.4.1-21.4.13 PMID: 18429165
- 2. Wang Y et al.. 2025. Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity.. Cell Metab 37(12):2323-2341.e6 PMID: 41260222
- 3. Song J et al.. 2023. The Effect of Metformin on Triple-Negative Breast Cancer Cells and Nude Mice.. Altern Ther Health Med 29(8):389-395 PMID: 37632970
- 4. Devarakonda CKV et al.. 2021. Coronavirus Receptors as Immune Modulators.. J Immunol 206(5):923-929 PMID: 33380494
- 5. Markland FS Jr et al.. 2013. Snake venom metalloproteinases.. Toxicon 62:3-18 PMID: 23000249
- 6. Zhang S et al.. 2024. Treadmill exercise improves cerebral ischemia injury by regulating microglia polarization via downregulation of MMP12.. Int Immunopharmacol 142(Pt B):113210 PMID: 39340990
- 7. Macaulay AD et al.. 2023. Initial detachment of the mouse oocyte from the zona pellucida is mediated by metallopeptidase activity†.. Biol Reprod 108(1):81-97 PMID: 36179245
